PATENT CLAIM ANALYSIS

Application Number: 16140224
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["514", "013200"]

Abstract:
The present invention provides methods for treating inflammatory or autoimmune disease using calcitonin receptor activators, such as calcitonin receptor activating antibodies, among others. The invention also features compositions containing calcitonin receptor activators, methods of diagnosing patients with calcitonin receptor-associated inflammatory or autoimmune disease, and methods of predicting the response of an inflammatory or autoimmune disease or condition in a subject to treatment with calcitonin receptor activators.

Claim (Index 1):
A method of treating a human subject identified as having an IL-6-associated inflammatory or autoimmune disease or condition, the method comprising administering to the subject an amount of a peptide or small molecule calcitonin receptor agonist effective to reduce IL-6 secretion by macrophages, thereby treating the subject.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.67442
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12122855', '13245279', '13867326', '12735932', '14211784']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7280363505379134
- 35 USC 102 Novelty (BERT): 0.4993729047273961
- Combined Prediction Score: 0.7051700059568617
- Mean Citation Score: 162.286666
- Max Citation Score: 164.1705
- Similarity Product: 94.9994513618946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test